Intercepting Cancer by Tackling Precancer
Guest Post by William G. Nelson, MD, PhDEditor-in-Chief, Cancer Today Clearly, cancers that have metastasized, or spread, to many different...
Progress Against Cancer
Guest Post by William G. Nelson, MD, PhDEditor-in-Chief, Cancer Today Clearly, cancers that have metastasized, or spread, to many different...
A study finds that younger patients are also more likely to be diagnosed at advanced stages of the disease,...
Study suggests that germline genetics may influence lung cancer risk in this patient population. Native American ancestry was associated...
Steroid is often used to prevent swelling in the brain, but may have “detrimental effect” on treatment with immune...
Algorithms can be trained to analyze patient data and histology images to predict if immune checkpoint blockade treatment will...
Disproportionate share of the burden of premature cancer deaths in the United States falls on racial and ethnic minorities...
Once thought sterile, lungs can harbor microbes that may affect lung cancer pathogenesis and prognosis. If microbes normally found...
Draft recommendation calls for screening at age 45, rather than 50. An influential panel of experts has issued a...
Results show importance of considering age of the patient in cancer treatment. How melanoma patients respond to a medication...
A new study reports that an inexpensive way to analyze DNA isolated from cells in urine is more sensitive...
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn MoreYour donation to the American Association for Cancer Research helps our more than 47,000 members worldwide drive progress against cancer.
Donate Now